Cvs Health (CVS) Short-term Investments (2009 - 2026)

Cvs Health (CVS) has 18 years of Short-term Investments data on file, last reported at $2.3 billion in Q1 2026.

• Quarterly Short-term Investments fell 12.34% year-over-year to $2.3 billion in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $2.3 billion (down 12.34% YoY) and the FY2025 annual result came in at $2.1 billion, down 10.88% from the prior year.
• Short-term Investments rose to $2.3 billion in Q1 2026, from $2.1 billion in the prior quarter.
• In the past five years, Short-term Investments ranged from a high of $3.8 billion in Q2 2024 to a low of $2.1 billion in Q3 2025.
• A 5-year average of $2.8 billion and a median of $2.8 billion in 2024 frame the typical range for Short-term Investments.
• Annual changes were most pronounced in 2024 — Short-term Investments climbed 21.92% — and 2025, when it tumbled 36.46%.
• Tracing CVS's Short-term Investments over 5 years: stood at $2.8 billion in 2022, then increased by 17.31% to $3.3 billion in 2023, then slipped by 26.14% to $2.4 billion in 2024, then retreated by 10.88% to $2.1 billion in 2025, then gained by 5.36% to $2.3 billion in 2026.
• The last three Short-term Investments figures came in at $2.3 billion (Q1 2026), $2.1 billion (Q4 2025), and $2.1 billion (Q3 2025), per Business Quant data.